Researchers at Princeton University have developed a 3-dimensional device that merges living brain cells ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, ...

The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 The materials will be made available in the ...

In an amazing twist of fate, the aggressive cervical cancer tumor that killed Henrietta Lacks, a 31-year old African American mother, became an essential tool that helped the biomedical field flourish ...

Whole-genome and transcriptome landscape of actionable driver-negative lung adenocarcinoma. Efficacy comparison in patients with low TPS (< 50%)/high IC score (≥ 1). Nivolumab plus ipilimumab-based ...

Recipharm Advanced Bio, a segment of CDMO Recipharm, and Infant Bacterial Therapeutics (IBT) began a process performance qualification (PPQ) for IBT’s lead product, IBP-9414. The PPQ program will take ...

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine ...

Sister companies aim to strengthen collaborations with biotech and pharmaceutical companies across South Korea and Asia by offering over two decades of expertise in biosafety and quality control ...

Labroots and the Cell Biology Planning Committee are pleased to announce the 9th Annual Event in the Cell Biology Virtual Event Series 2025 on September 17th, 2025. This event provides an opportunity ...